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We have investigated the changes in the protein syn-
thesis pattern in guinea pig peritoneal macrophages 
following infection with virulent Mycobacterium tu-
berculosis H37Rv in vitro. By 35S methionine label-
ling of the newly synthesized proteins followed by 
ultracentrifugation, SDS-PAGE (sodium dodecyl 
sulphate polyacrylamide gel electrophoresis) and 
autoradiography, the protein synthesis pattern of the 
control uninfected macrophages and the infected 
macrophages in vitro were compared. By adding 
cycloheximide to the macrophage cultures, the pro-
tein synthesis of macrophages was inhibited and the 
protein synthesis pattern of M. tuberculosis has been 
analysed. We have identified a mycobacterial protein 
of molecular weight 17 kDa which was expressed 
exclusively in the cytosolic fraction of M. tuberculo-
sis-infected guinea pig macrophages in vitro. 
 
TUBERCULOSIS is a major cause of morbidity and mor-
tality worldwide. There is an enormous increase in the 
incidence of tuberculosis due to HIV epidemic and rise 
in multi-drug resistance. Mycobacterium tuberculosis is 
one of the successful intracellular pathogens infecting 
over one-third of the world’s population and causing 8 
million new cases of active tuberculosis annually1. The 
resurgence of tuberculosis has highlighted the need for 
new strategies to combat M. tuberculosis. To develop 
such strategies, one needs to learn more about the 
pathogensis of M. tuberculosis infection. 
 M. tuberculosis is an intracellular pathogen. The 
macrophage fails to eliminate this pathogen in spite of 
the powerful array of antimicrobial defences it puts 
forth, along with other components of the immune sys-
tem. This shows that M. tuberculosis adopts itself to the 
intracellular environment by mounting a response ap-
propriate to ensure its survival. The resistance by M. 
tuberculosis would involve a number of genes. The pro-
tein products of these genes could not only be potential 
virulent determinants but also important in cell-
m iated and protective immune response to M. tuber-
culosis, because they are processed and presented by 
infected macrophages. So it becomes imperative to 
identify and characterize M. tuberculosis proteins which 
would help us to understand the pathogenesis of tuber-
culosis and in turn to develop novel drug targets and 
attenuated vaccines. 
 To understand these mechanisms, the bacterial gene 
products that are specifically required at each stage of 
the infection process have to be identifie . It has been 
demonstrated by Buchmeir and Heffron2 that virulent 
Salmonella strains upon phagocytosis by a macrophage 
cell line express at least 30 different prot ins. Monahan 
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et al.3 studied the protein synthesis profile in response 
to peroxide and demonstrated the induction of  
heat shock proteins (hsp) 60, 70 and 90 with minor 
changes, when M. bovis BCG was cultured in Dubos 
broth using metabolic labelling, SDS-PAGE and 
autoradiography. 
 It is therefore possible to analyse the protein synthe-
sis patterns associated with host–pathogen interaction 
and study the host factors that induce an adaptive 
pathogen response. This appro ch might be helpful to 
define the molecular mechanisms involved in host–
pathogen interactions. 
 We undertook the study to identify the protein prod-
ucts which are uniquely expressed by M. tuberculosis in 
the intracellular environment of the guinea pig macro-
phages in vitro. We chose guinea pigs because the tu-
berculosis disease in this animal model mimics the 
disease in humans. 
 Eight-week-old inbred guinea pigs were injected in-
traperitoneally with 2% sterile starch. Seventy-two 
hours later, the peritoneal cavity was washed with ice-
cold Hanks balanced salt solution (HBSS) (Bio Whitta-
kor, Walkersville, MD, USA). The number of macro-
phages in the peritoneal lavage was ascertained by 
neutral red staining (approximately 90–95% were 
macrophages). 
 Macrophages recovered from the peritoneal cavity 
were suspended in RPMI medium (Siga Chemical Co, 
St. Louis, MO, USA) without methionine. Macrophages 
were cultured in 12 well-tissue culture plates (1 mil-
lion/well). The cells were allowed to adhere at 37°C, 
5% CO2, in a humidified atmosphere for 60 min. The 
non-adherent cells were removed by gentle washing and 
the adherent macrophages were cultured in RPMI 
(without methionine) containing 5% foetal calf serum 
(FCS) (Sigma Chemical Co, USA). 
 Starch-elicited guinea pig peritoneal macroph ges in 
vitro were infected with M. tuberculosis, M. bovis BCG, 
heat killed M. tuberculosis, yeast and Listeria monocy-
togenes eparately. The macrophage to organism ratio 
was adjusted to 1 : 10 (i.e. for every single macrophage, 
there were ten organisms). One hour after infection, the 
unphagocytosed organisms were removed by gentle 
washing. 35S methionine (Board of Radiation and Iso-
tope Technology, Mumbai, India) (10 µCi/well) was 
added to the infected macrophages. 
 The cultures were terminated 48 h after infection. The 
macrophages were lysed with ice-cold lysis buffer (1% 
CHAPS [3-cholamidopropyl dimethylammonio] 1 pr-
pane sulphate), 3 mM EDTA (ethylene diamine 
tetraacetic acid, 2 mM PMSF (phenyl methyl sulphonyl 
fluoride), 1.7 TIU/ml aprotonin and 100 mM iodo 
acetamide in PBS (Sigma Chemical Co, USA). The lys-
ate was centrifuged at 5000 rpm for 10 min. The super-
natant was ultracentrifuged at 45,000 rpm for 45 min. 
The supernatant obtained from ultracentrifugation 
represents cytosolic fraction of the macrophages. The 
proteins in the supernatant were resolved by SDS-
PAGE and transferred onto nitrocellul s  paper (NCP)4. 
The NCP was exposed to an X-ray film, which was later 
developed. 
 M. tuberculosis H37Rv was cultured in RPMI without 
methionine with 5% FCS for one week. The organisms 
were pelleted by centrifugation at 10,000 rpm for 
10min. The pellet was supended in 2 ml of RPMI. The 
suspension was subjected to sonication by ultrasonic 
vibration (soniprep 150 MSE, UK) for 10 min in ice. 
The viability of M. tuberculosis in the sonicate prepara-
tion was confirmed by plating in 7H11 with oleic acid 
dextrose complex (OADC) (Difco Laboratories, Detroit, 
MI, USA). The culture filtrate antige  was prepared as 
follows: M. tuberculosis was cultured in RPMI without 
methionine with 5% FCS for one week. The organisms 
were pelleted by centrifugation at 10,000 rpm for 
10 min. The cell-free supernatant was lyophilized. The 
lyophilized pellet fraction was made up to 200 ml with 
normal saline. 
 M. tuberculosis H37Rv and M. bovis BCG were cul-
tured in Dubos broth containing Tween 80. A single-
cell suspension of mycobacteria at peak log phase of 
growth was used for infection. At the time of infection, 
the bacterial cell suspension was washed three times in 
HBSS to remove Tween 80. The bacterial cell suspen-
sion was subjected to mild sonication, to disaggregate 
the clumps. The number of mycobacteria in the suspen-
sion was ascertained by counts in Thoma counting 
chamber. Heat-killed M. tuberculosis cell suspension 
was prepared by incubating M. tuberculosis cell suspen-
sion at 80oC, in water bath for 20 min.
 Heat-killed yeast particles were suspended in normal 
saline. At the time of infection, the yeast particles were 
sonicated to disaggregate the clumps and the total num-
ber of yeast particles in the suspension was ascertained 
by counts in Neubauer counting chamber. 
 Listeria monocytogenes wa  cultured in blood agar in 
the presence of carbon dioxide. Single colonies of L. 
monocytogenes were recovered from blood agar and 
washed three times in HBSS. The clumps were dis-
persed by vigorous vortexing. The number of organisms 
present in the suspen ion was ascertained by counts in 
Thoma counting chamber. 
 More than 40 bands were observed both in the cyto-
solic and membrane fraction from the infected and unin-
fected macrophages (data not shown). More strikingly, 
one of the proteins of cytosolic fraction from M. tuber-
culosis-infected macrophages was highlighted promi-
nently compared to the cytosolic fraction from 
uninfected macrophages in vitro (Figure 1). This protein 
has been identified consistently on five occasions, when 
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Figure 1. Unique protein of the cytosolic fraction from M. tubercu-
losis-infected macrophages as shown by autoradiogram. Lanes 1 and 
2 represent cytosolic frations from uninfected macrophages and M. 
tuberculosis- nfected macrophages, respectively. Lane M represents 
the molecular weight marker. The dotted line points to the unique 
protein expressed in M. tuberculosis-infected macrophages. Equiva-





Figure 2. Differential expression of a protein by intracellular M. 
tuberculosis compared to cell-free system. Lanes 1 to 4 represent 
cytosolic fractions from uninfected macrophages and M. tuberculo-
sis-infected macrophages, sonicate antigen and culture filtrate anti-
gen from M. tuberculosis, respectively. Arrow points to the unique 
protein expressed by M. tuberculosis infected macrophages. Equiva-
lent counts (cts) (250,000 cts min–1) were applied to each lane. 
 
 
 The unique protein was not expressed in a cell-free
system where M. tuberculosis  cultured in RPMI or 
Dubos broth without macrophages. Figure 2 shows the 
pattern obtained with sonicate and culture filtrate anti-
gen from 35S methionine-labelled bacilli resolved in 
SDS-PAGE, in parallel with the cytosolic fraction from 
infected and uninfected macrophages. The sonicate and 
culture filtrate antigen does not show the unique band 
of molecular weight around 17 kDa, implicating that 
this protein is produced by M. tuberculosis on entry into 
the macrophages.  
 Further, to analyse whether viable bacilli alone are 
capable of inducing this protein, macrophages were in-
fected with heat-killed M. tuberculosis. The cytosolic 
fraction of the macrophages infected either with heat-
killed M. tuberculosis or heat-killed yeast did not ex-
press this protein (Figure 3). Other intracellular patho-
gens like L. monocytogenes al o did not induce this 
protein on phagocytosis. M. bovis BCG-infected macro-
phages induced this protein to a lower level (data not 
shown).  
 The next question was to find out the origin of the 
cytosolic protein; whether it is synthesized by macro-
phages upon infection with M. tuberculosis or synthe-
sized by M. tuberculosis after getting phagocytosed. 
Cycloheximide is known to inhibit the protein synthesis 
of eukaryotes. Hence cycloheximide at two different 
concentrations of 50 and 100 µg/ml was included in the 
experiment. At a concentration of 100 µg/ml, cyclo-
heximide was able to inhibit the protein synthesis of the 
m crophages. Among the mycobacterial proteins visible 
in the autoradiogram, the unique band with a molecul r 
weight of around 17 kDa was also observed only in the 
infected macrophages in the presence of cycloheximide 
(Figure 4). This clearly reveals that this protein is pro-
duced by M. tuberculosis following entry into macro-
phages. 
 M. tuberculosis nfection is usually transmitted via 
the air-borne route. This intracellular pathogen, after 
entry into the body, invades the macrophages. The 
macrophages act as reservoirs, where it can remain for 
years before embarking an orgy of destruction in the 
victims lungs, that leads to disease and illness5. Our 
understanding of the pathogenicity has often lagged 
behind knowledge of host responses to infection. An 
understanding of the mechanism of bacterial pathogene-
sis is dependent on the identification and characteriza-
tion of the microbial gene product that influences the 
progression of the disease. 
 Virulent tubercle bacilli multiply freely within the 
macrophages6. Unlike the other intracellular pathogens 
whose virulence factors are known like adhesins, inva-
sins and hemolysins, we do not know the virulence fac-
tor for M. tuberculosis. Over the years, a number of 
systems have been tried for the study of mycobacterial 
virulence. Arruda et al.7 used a non-i vasive strain of 
Escherichia coli as a surrogate host, to identify the 
DNA fragment responsible for the ability of M. tubercu-
losis to bind to and subsequently invade HeLa cells. 
Kinger and Tyagi8 analysed the differences in gene ex-
pression between the avirulent H37Ra and virule t
H37Rv using susbtractive hybridization. They identified 
5 mRNAs present in both strains, but preferentially ex-
presse  in the virulent strain. Mundayoor and Shinnick9 
used a library of M. tuberculosis DNA in M. smegmatis 
and identified genes that increased the intracellular sur-
vival of the bacteria transiently, but the genes were 
ve  fully characterized. A macrophage-induced gen  
or mig was identified. This encodes a 27 kD protein of 
unknown function and is absent in the M. uberculosis 
culture10. The study of virulence has also been at-
tempted using a new technology called in vivo
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Figure 3. Comparison of protein synthesis pattern of M. tuberculo-
sis-infected macrophages with those infected with heat-killed M. 
tuberculosis and yeast. Lanes 1 to 4 represent cytosolic fractions 
from uninfected macrophages and M. tuberculosis-infected macro-
phages, heat-killed yeast-phagocytised macrophages and heat-kill d 
M. tuberculosis-phagocytised macrophages, respectively. The arrow 
points to the unique protein expressed by the cytosolic fraction from 
M. tuberculosis-infected macrophages. Equivalent counts (cts) 




Figure 4. SDS-PAGE followed by autoradiogram shows that intra-
cellular M. tuberculosis synthesize 17 kDa protein. Lanes 1 to 4 
represent cytosolic fractions from uninfected macrophages, cyclo-
heximide-treated uninfected macrophages, M. tuberculosis-infected 
macrophages and M. tuberculosis-infected cycloheximide-treated 
macrophages, respectively. Lane M represents the molecularweight 
marker. The arrows point to the unique protein expressed by the cytosolic 
fraction from M. tuberculosis-infected macrophages and from M. tubercu-
losis-infected cycloheximide-treated macrophages. Equivalent counts (cts) 
(300,000 cts min–1) were applied to each lane. 
 
expression technology or IVET, which can positively 
select bacterial genes that are induc d within their host 
and this technique has been successfully used in Salmo-
nella11. In spite of similar attempts, the virulence factor of 
M. tuberculosis has not been identified and characterized. 
 It is possible that tubercle bacilli may undergo impor-
tant phenotypic changes in vivo, which contribute to 
virulence. So we have used a new strategy of identify-
ing directly, the protein which is differentially ex-
pressed by M. tuberculosis in the intracellular 
environment of the guinea pig macrophages in vitro. We 
have attempted to analyse the protein synthesis patterns 
associated with host–pa hogen interactions by labelling 
the proteins synthesized soon after the entry of M. u-
berculosis inside the guinea pig macrophages in vitro 
with 35S methionine, followed by ultracentrifugation, 
SDS-PAGE and autoradiography. It will be interes ing 
to further characterize the prot ins of M. tuberculosis 
induced inside the macrophages and study their role in 
the pathogenesis. 
 We now report a protein of molecular weight of 
around 17 kDa, produced by M. tuberculosis only inside 
the intracellular environment of guinea pig macro-
phages cultured in vitro. Future experiments will be 
focused on isolation, purification and characterization 
of this unique protein using immunological and molecu-
lar biological methods and to study whether this protein 
has any role in the pathogenesis of the disease. Re-
cently, Yuan et al.12 reported a protein of molecular 
weight 16 kDa limited to the slowly-growing M. tuber-
culosis complex organisms. 16kDa protein was over 
expressed during the stationary phase of growth. We 
have observed earlier that the tubercle bacilli after be-
ing phagocytosed by the macrophages remain stationary 
up to 72 h without multiplication, as shown by our in-
tracellular killing assay (unpublished observation). It 
will be interesting to see whether this 17 kDa protein 
has a role to play in the intracellular survival of M. tu-
berculosis.  
 Demonstration of the presence of a unique putative 
protein or virulence determinant  vivo is one of the 
difficult tasks. As a first step, we have demonstrated 
that the unique protein is produced by M. tuberculosis 
in a host environment in vivo. 
 Future research should unravel the role of this protein 
in the pathogenesis of the disease and may suggest tar-
gets for therapeutic intervention to eradicate such or-
ganisms.  
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